211 related articles for article (PubMed ID: 19934764)
1. Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a Botswana Experience, 2004-2006.
Mosimaneotsile B; Mathoma A; Chengeta B; Nyirenda S; Agizew TB; Tedla Z; Motsamai OI; Kilmarx PH; Wells CD; Samandari T
J Acquir Immune Defic Syndr; 2010 May; 54(1):71-7. PubMed ID: 19934764
[TBL] [Abstract][Full Text] [Related]
2. Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana.
Tedla Z; Nyirenda S; Peeler C; Agizew T; Sibanda T; Motsamai O; Vernon A; Wells CD; Samandari T
Am J Respir Crit Care Med; 2010 Jul; 182(2):278-85. PubMed ID: 20378730
[TBL] [Abstract][Full Text] [Related]
3. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
4. Isoniazid-associated hepatitis in adults infected with HIV receiving 36 months of isoniazid prophylaxis in Botswana.
Tedla Z; Nguyen ML; Sibanda T; Nyirenda S; Agizew TB; Girde S; Rose CE; Samandari T
Chest; 2015 May; 147(5):1376-1384. PubMed ID: 25340318
[TBL] [Abstract][Full Text] [Related]
5. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.
Samandari T; Agizew TB; Nyirenda S; Tedla Z; Sibanda T; Shang N; Mosimaneotsile B; Motsamai OI; Bozeman L; Davis MK; Talbot EA; Moeti TL; Moffat HJ; Kilmarx PH; Castro KG; Wells CD
Lancet; 2011 May; 377(9777):1588-98. PubMed ID: 21492926
[TBL] [Abstract][Full Text] [Related]
6. Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy.
van Griensven J; Choun K; Chim B; Thai S; Lorent N; Lynen L
Trop Med Int Health; 2015 Dec; 20(12):1823-31. PubMed ID: 26426387
[TBL] [Abstract][Full Text] [Related]
7. Anti-tuberculosis treatment outcomes in HIV-infected adults exposed to isoniazid preventive therapy in Botswana.
Sibanda T; Tedla Z; Nyirenda S; Agizew T; Marape M; Miranda AG; Reuter H; Johnson JL; Samandari T
Int J Tuberc Lung Dis; 2013 Feb; 17(2):178-85. PubMed ID: 23317952
[TBL] [Abstract][Full Text] [Related]
8. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
[TBL] [Abstract][Full Text] [Related]
9. Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.
Smith T; Samandari T; Abimbola T; Marston B; Sangrujee N
J Acquir Immune Defic Syndr; 2015 Nov; 70(3):e84-93. PubMed ID: 26258564
[TBL] [Abstract][Full Text] [Related]
10. The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis.
Geremew D; Endalamaw A; Negash M; Eshetie S; Tessema B
BMC Infect Dis; 2019 May; 19(1):405. PubMed ID: 31077133
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
Semu M; Fenta TG; Medhin G; Assefa D
BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
[TBL] [Abstract][Full Text] [Related]
12. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.
Golub JE; Saraceni V; Cavalcante SC; Pacheco AG; Moulton LH; King BS; Efron A; Moore RD; Chaisson RE; Durovni B
AIDS; 2007 Jul; 21(11):1441-8. PubMed ID: 17589190
[TBL] [Abstract][Full Text] [Related]
13. To start or to complete? - Challenges in implementing tuberculosis preventive therapy among people living with HIV: a mixed-methods study from Karnataka, India.
Reddy MM; Thekkur P; Ramya N; Kamath PBT; Shastri SG; Kumar RBN; Chinnakali P; Nirgude AS; Rangaraju C; Somashekar N; Kumar AMV
Glob Health Action; 2020; 13(1):1704540. PubMed ID: 31937200
[No Abstract] [Full Text] [Related]
14. Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania.
Shayo GA; Moshiro C; Aboud S; Bakari M; Mugusi FM
BMC Infect Dis; 2015 Aug; 15():368. PubMed ID: 26306511
[TBL] [Abstract][Full Text] [Related]
15. Hepatotoxicity During Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living With HIV With Severe Immunosuppression: A Secondary Analysis of a Multi-Country Open-Label Randomized Controlled Clinical Trial.
Ngongondo M; Miyahara S; Hughes MD; Sun X; Bisson GP; Gupta A; Kumwenda J; Lavenberg JA; Torres TS; Nyirenda M; Kidonge KK; Hosseinipour MC;
J Acquir Immune Defic Syndr; 2018 May; 78(1):54-61. PubMed ID: 29406428
[TBL] [Abstract][Full Text] [Related]
16. Completion of isoniazid preventive therapy among human immunodeficiency virus positive adults in urban Malawi.
Thindwa D; MacPherson P; Choko AT; Khundi M; Sambakunsi R; Ngwira LG; Kalua T; Webb EL; Corbett EL
Int J Tuberc Lung Dis; 2018 Mar; 22(3):273-279. PubMed ID: 29471904
[TBL] [Abstract][Full Text] [Related]
17. Isoniazid preventive therapy use among patients on antiretroviral therapy: a missed opportunity.
Kufa T; Chihota VN; Charalambous S; Churchyard GJ
Int J Tuberc Lung Dis; 2014 Mar; 18(3):312-4. PubMed ID: 24670568
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis in asymptomatic HIV-infected adults with abnormal chest radiographs screened for tuberculosis prevention.
Agizew TB; Arwady MA; Yoon JC; Nyirenda S; Mosimaneotsile B; Tedla Z; Motsamai O; Kilmarx PH; Wells CD; Samandari T
Int J Tuberc Lung Dis; 2010 Jan; 14(1):45-51. PubMed ID: 20003694
[TBL] [Abstract][Full Text] [Related]
19. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
Golub JE; Pronyk P; Mohapi L; Thsabangu N; Moshabela M; Struthers H; Gray GE; McIntyre JA; Chaisson RE; Martinson NA
AIDS; 2009 Mar; 23(5):631-6. PubMed ID: 19525621
[TBL] [Abstract][Full Text] [Related]
20. Implementing isoniazid preventive therapy in a tuberculosis treatment-experienced cohort on ART.
Maharaj B; Gengiah TN; Yende-Zuma N; Gengiah S; Naidoo A; Naidoo K
Int J Tuberc Lung Dis; 2017 May; 21(5):537-543. PubMed ID: 28399969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
